Effects of Chronic Sleep Fragmentation and Diet Restriction on Appetite-Regulating Hormones and Cardiometabolic Indicators

만성 분절수면과 식이제한이 식욕조절 호르몬 및 심혈관 위험지표에 미치는 영향

  • Jun, Nuri (Department of Foods and Nutrition, College of Natural Sciences, Kookmin University) ;
  • Baik, Inkyung (Department of Foods and Nutrition, College of Natural Sciences, Kookmin University)
  • 전누리 (국민대학교 자연과학대학 식품영양학과) ;
  • 백인경 (국민대학교 자연과학대학 식품영양학과)
  • Received : 2016.09.12
  • Accepted : 2017.01.17
  • Published : 2017.02.28


Data are limited on biological mechanisms underlying the associations of sleep insufficiency with obesity and dyslipidemia. To explore these mechanisms, we investigated appetite-regulating hormones, stress-related hormones, and cardiometabolic indicators in association with sleep fragmentation, which is a type of sleep disorder. In an experimental study, we randomly allocated 40 Wistar male rats aged 7 weeks into four groups; rats with ad libitum sleep and ad libitum intake (Control), those exposed to sleep fragmentation (SF), those with diet restriction (DR), and those exposed to sleep fragmentation and diet restriction (SF+DR). Amongst them, 13-day chronic sleep fragmentation was applied to the SF and SF+DR groups while 50% reduction in chow intake was applied to the DR and SF+DR groups for 13 days. After these experiments, blood lipid and lipoprotein profiles, leptin, ghrelin, adiponectin, cortisol, epinephrine, and norepinephrine levels were compared among the four groups. In the results, the SF group showed the highest levels of serum ghrelin (P<0.001) and the lowest levels of serum adiponectin (P<0.01). All experimental groups showed higher levels of low density lipoprotein-cholesterol (LDL-C) than the Control (P<0.001). LDL-C levels and the ratio of LDL-C and high density lipoprotein-cholesterol were positively correlated with ghrelin levels (P<0.05) in the SF group, but not in the DR and SF+DR groups. In the SF group, the highest levels of serum free fatty acids were also observed and correlated with lower levels of serum adiponectin, which reflects insulin resistance (P<0.05). Based on these findings, we suggest that chronic sleep fragmentation may induce disturbances in lipid metabolism and appetite-regulating hormones independent of food intake, and these metabolic disturbances may be worse due to insulin resistance related to overeating, which is indicated by elevated ghrelin levels in sleep fragmentation. For persons with sleep insufficiency, anti-atherogenic dietary interventions may be recommended to prevent cardiovascular disease.


  1. Taheri S, Lin L, Austin D, Young T, Mignot E. 2004. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 1: e62.
  2. Yaggi HK, Araujo AB, McKinlay JB. 2006. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care 29: 657-661.
  3. Gottlieb DJ, Redline S, Nieto FJ, Baldwin CM, Newman AB, Resnick HE, Punjabi NM. 2006. Association of usual sleep duration with hypertension: The Sleep Heart Health Study. Sleep 29: 1009-1014.
  4. Ayas NT, White DP, Manson JE, Stampfer MJ, Speizer FE, Malhotra A, Hu FB. 2003. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med 163: 205-209.
  5. Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. 2002. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 59: 131-136.
  6. Patel SR, Hu FB. 2008. Short sleep duration and weight gain: a systematic review. Obesity 16: 643-653.
  7. Newman AB, Nieto FJ, Guidry U, Lind BK, Redline S, Shahar E, Pickering TG, Quan SF, Sleep Heart Health Study Research Group. 2001. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 154: 50-59.
  8. Roche F, Sforza E, Pichot V, Maudoux D, Garcin A, Celle S, Picard-Kossovsky M, Gaspoz JM, Barthelemy JC, PROOF Study Group. 2009. Obstructive sleep apnoea/hypopnea influences high-density lipoprotein cholesterol in the elderly. Sleep Med 10: 882-886.
  9. Haseli-Mashhadi N, Dadd T, Pan A, Yu Z, Lin X, Franco OH. 2009. Sleep quality in middle-aged and elderly Chinese: distribution, associated factors and associations with cardio-metabolic risk factors. BMC Public Health 9: 130.
  10. Martins PJ, Fernandes L, de Oliveira AC, Tufik S, D'Almeida V. 2011. Type of diet modulates the metabolic response to sleep deprivation in rats. Nutr Metab 8: 86.
  11. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. 2001. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7: 941-946.
  12. Knutson KL, Van Cauter E. 2008. Associations between sleep loss and increased risk of obesity and diabetes. Ann N Y Acad Sci 1129: 287-304.
  13. Van Cauter E, Knutson KL. 2008. Sleep and the epidemic of obesity in children and adults. Eur J Endocrinol 159: S59-S66.
  14. Nedeltcheva AV, Kilkus JM, Imperial J, Kasza K, Schoeller DA, Penev PD. 2009. Sleep curtailment is accompanied by increased intake of calories from snacks. Am J Clin Nutr 89: 126-133.
  15. Shi Z, McEvoy M, Luu J, Attia J. 2008. Dietary fat and sleep duration in Chinese men and women. Int J Obes (Lond) 32: 1835-1840.
  16. Baik I, Jun N, Yoon D, Shin C. 2013. Sleep fragmentation affects LDL-cholesterol and adipocytokines independent of food intake in rats. Sleep Biol Rhythms 11: 74-81.
  17. Yoon DW, Lee SK, Yun CH, Baik IK, Shin C. 2012. Validation of a walking wheel method to fragment sleep in rats. Sleep Med Res 3: 7-14.
  18. Balogh Z, Foris G, Kosztaczky B, Paragh G Jr, Seres I, Zsiros E, Konya G, Paragh G. 2007. The concentration dependent biphasic effect of leptin on endogenous cholesterol synthesis in human monocytes. Peptides 28: 2081-2083.
  19. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T. 2002. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288-1295.
  20. Dubuc GR, Phinney SD, Stern JS, Havel PJ. 1998. Changes of serum leptin and endocrine and metabolic parameters after 7 days of energy restriction in men and women. Metabolism 47: 429-434.
  21. Asterholm IW, Scherer PE. 2010. Enhanced metabolic flexibility associated with elevated adiponectin levels. Am J Pathol 176: 1364-1376.
  22. 2008 sleep in America poll. National Sleep Foundation. (accessed Aug 2016).